Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fluid Synchrony
AddedFeb 16, 2024
UpdatedJun 18, 2026
Fluid Synchrony

Fluid Synchrony

Pre-Seed

Fluid Synchrony, a US-based company, offers precise, controlled, and personalized microinfusion drug delivery systems.

HQ
Pasadena, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Fluid Synchrony, based in Pasadena, United States, specializes in advanced microinfusion technology designed to provide precise, controlled, and personalized drug delivery. Their patented microtechnologies enable the safe and localized delivery of various liquid drug formulations directly to diseased tissue. The system supports wireless control, on-demand programming, and remote monitoring, allowing for evidence-based and personalized drug therapy. Fluid Synchrony’s solutions are ideal for chronic treatments and are applicable across a wide range of animal models.

Fluid Synchrony has made significant strides in the field of microinfusion technology, offering a miniaturized pump system that enhances dosing flexibility and safety. Their programmable electronic dosing control simplifies complex dosing regimens, making it easier for researchers and medical professionals to manage chronic treatments. The company's innovative use of MEMS (Micro-Electro-Mechanical Systems) technology has positioned them as a leader in the market for precise drug delivery systems, contributing to more effective and personalized medical treatments.

Fluid Synchrony - Similar Companies

Infini Fluidics logo

Infini Fluidics

Fluonic logo

Fluonic

SFC Fluidics logo

SFC Fluidics

sfc-fluidics.com

Parallel Fluidics logo

Parallel Fluidics

Aqueduct Fluidics logo

Aqueduct Fluidics

Neofluidics logo

Neofluidics

Petl Fluidics logo

Petl Fluidics

petlfluidics.com

Spectrafluidics logo

Spectrafluidics

Flow Circuits logo

Flow Circuits

flowcircuits.com

Microfluidic Innovations logo

Microfluidic Innovations

Enable Injections logo

Enable Injections

SpheroFill logo

SpheroFill

spherofill.net

Medipacs logo

Medipacs

medipacs.com

Controlled Delivery Systems logo

Controlled Delivery Systems

RxActuator logo

RxActuator

Fluid Synchrony - Quick Facts

Who are Fluid Synchrony's competitors?

Companies similar to Fluid Synchrony include Infini Fluidics, Fluonic, SFC Fluidics and Parallel Fluidics.

When was Fluid Synchrony founded?

Fluid Synchrony was founded in 2010.

Where is Fluid Synchrony's headquarters located?

Fluid Synchrony's headquarters is located in Pasadena, CA, US.

When was Fluid Synchrony's last funding round?

Fluid Synchrony's most recent funding round was for $1.5M (USD) in April 2014.

How much has Fluid Synchrony raised to-date?

As of Apr 7, 2014, Fluid Synchrony has raised a total of $1.7M (USD).

How many employees does Fluid Synchrony have?

Fluid Synchrony has 2 employees as of Feb 4, 2024.

Fluid Synchrony - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
  • Microfluidics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified